Low-Density Lipoprotein Cholesterol Treatment Rates in High Risk Patients: More Disappointment Despite Ever More Refined Evidence-Based Guidelines.
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2021-06-01
|
| Series: | American Journal of Preventive Cardiology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666667721000416 |
| _version_ | 1818932982775283712 |
|---|---|
| author | Peter P. Toth, MD, PhD |
| author_facet | Peter P. Toth, MD, PhD |
| author_sort | Peter P. Toth, MD, PhD |
| collection | DOAJ |
| first_indexed | 2024-12-20T04:41:08Z |
| format | Article |
| id | doaj.art-e4189993ba9845ef8a1784727ee6cdde |
| institution | Directory Open Access Journal |
| issn | 2666-6677 |
| language | English |
| last_indexed | 2024-12-20T04:41:08Z |
| publishDate | 2021-06-01 |
| publisher | Elsevier |
| record_format | Article |
| series | American Journal of Preventive Cardiology |
| spelling | doaj.art-e4189993ba9845ef8a1784727ee6cdde2022-12-21T19:53:08ZengElsevierAmerican Journal of Preventive Cardiology2666-66772021-06-016100186Low-Density Lipoprotein Cholesterol Treatment Rates in High Risk Patients: More Disappointment Despite Ever More Refined Evidence-Based Guidelines.Peter P. Toth, MD, PhD0Contact Information: CGH Main Clinic, 101 East Miller Rd. Sterling, Illinois 61081, Tel: (815) 625-4790.; CGH Medical Center Sterling, Illinois 61081, Cicarrone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205http://www.sciencedirect.com/science/article/pii/S2666667721000416Atherosclerotic cardiovascular diseaseEzetimibeLipid-lowering therapyLow-density lipoprotein cholesterolMyocardial infarctionStatin |
| spellingShingle | Peter P. Toth, MD, PhD Low-Density Lipoprotein Cholesterol Treatment Rates in High Risk Patients: More Disappointment Despite Ever More Refined Evidence-Based Guidelines. American Journal of Preventive Cardiology Atherosclerotic cardiovascular disease Ezetimibe Lipid-lowering therapy Low-density lipoprotein cholesterol Myocardial infarction Statin |
| title | Low-Density Lipoprotein Cholesterol Treatment Rates in High Risk Patients: More Disappointment Despite Ever More Refined Evidence-Based Guidelines. |
| title_full | Low-Density Lipoprotein Cholesterol Treatment Rates in High Risk Patients: More Disappointment Despite Ever More Refined Evidence-Based Guidelines. |
| title_fullStr | Low-Density Lipoprotein Cholesterol Treatment Rates in High Risk Patients: More Disappointment Despite Ever More Refined Evidence-Based Guidelines. |
| title_full_unstemmed | Low-Density Lipoprotein Cholesterol Treatment Rates in High Risk Patients: More Disappointment Despite Ever More Refined Evidence-Based Guidelines. |
| title_short | Low-Density Lipoprotein Cholesterol Treatment Rates in High Risk Patients: More Disappointment Despite Ever More Refined Evidence-Based Guidelines. |
| title_sort | low density lipoprotein cholesterol treatment rates in high risk patients more disappointment despite ever more refined evidence based guidelines |
| topic | Atherosclerotic cardiovascular disease Ezetimibe Lipid-lowering therapy Low-density lipoprotein cholesterol Myocardial infarction Statin |
| url | http://www.sciencedirect.com/science/article/pii/S2666667721000416 |
| work_keys_str_mv | AT peterptothmdphd lowdensitylipoproteincholesteroltreatmentratesinhighriskpatientsmoredisappointmentdespiteevermorerefinedevidencebasedguidelines |